Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Eculizumab 300 mg/30 mL Soln 30 mL Vial (CDM 81696) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 3, 2026 , from http://ppman.hank.ai/transparency/procedure/81696/by-state?code_type=CDM
“Eculizumab 300 mg/30 mL Soln 30 mL Vial (CDM 81696) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/81696/by-state?code_type=CDM. Accessed
November 3, 2026 .
“Eculizumab 300 mg/30 mL Soln 30 mL Vial (CDM 81696) by State,” HANK Price Transparency ,
accessed November 3, 2026 ,
http://ppman.hank.ai/transparency/procedure/81696/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
81696 — Eculizumab 300 Mg/30 Ml Soln 30 Ml Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,068
National median
$579 – $61,729
IQR (p25 – p75)
19
hospitals filing
10
states
Walking in without insurance?
Cash / self-pay price
Cash median
$5,021
vs. negotiated
+63.6%
Hospitals reporting
22
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 81696 (CDM), with interquartile range
State Median p25 p75
TX $51 $28 $80
CA $477 $347 $477
WI $478 $366 $560
UT $1,142 $867 $1,443
KY $1,534 $462 $2,573
VA $2,745 $1,696 $5,254
NH $3,005 $2,017 $3,637
CT $12,394 $4,927 $17,938
NE $13,090 $12,952 $13,228
FL $110,514 $62,996 $132,291